WCLC 2024: Analyzing SKIPPirr Data Outcomes for Lung Cancer Advancements

In this video, panelists discuss how the SKIPPirr data outcomes presented at World Conference for Lung Cancer 2024 provide valuable insights into the potential use of amivantamab for advancing lung cancer treatment strategies. Watch here.